Annual Cash & Cash Equivalents
$3.20 M
+$2.56 M+396.59%
December 31, 2023
Summary
- As of February 7, 2025, KRBP annual cash & cash equivalents is $3.20 million, with the most recent change of +$2.56 million (+396.59%) on December 31, 2023.
- During the last 3 years, KRBP annual cash & cash equivalents has fallen by -$6.95 million (-68.44%).
- KRBP annual cash & cash equivalents is now -87.36% below its all-time high of $25.35 million, reached on December 31, 2021.
Performance
KRBP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.92 M
-$1.12 M-27.77%
September 30, 2024
Summary
- As of February 7, 2025, KRBP quarterly cash and cash equivalents is $2.92 million, with the most recent change of -$1.12 million (-27.77%) on September 30, 2024.
- Over the past year, KRBP quarterly cash and cash equivalents has dropped by -$1.12 million (-27.77%).
- KRBP quarterly cash and cash equivalents is now -91.68% below its all-time high of $35.16 million, reached on September 30, 2021.
Performance
KRBP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KRBP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +396.6% | -27.8% |
| 3 y3 years | -68.4% | +8.1% |
| 5 y5 years | +733.7% | +8.1% |
KRBP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.4% | +396.6% | -88.5% | +575.8% |
| 5 y | 5-year | -87.4% | +396.6% | -91.7% | +575.8% |
| alltime | all time | -87.4% | +733.7% | -91.7% | +575.8% |
Kiromic BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.92 M(-27.8%) |
| Jun 2024 | - | $4.05 M(+10.1%) |
| Mar 2024 | - | $3.68 M(+14.7%) |
| Dec 2023 | $3.20 M(+396.6%) | $3.20 M(-26.8%) |
| Sep 2023 | - | $4.38 M(+62.0%) |
| Jun 2023 | - | $2.70 M(+31.6%) |
| Mar 2023 | - | $2.05 M(+218.4%) |
| Dec 2022 | $645.20 K | $645.20 K(+49.1%) |
| Sep 2022 | - | $432.70 K(-93.4%) |
| Jun 2022 | - | $6.51 M(-56.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $15.12 M(-40.4%) |
| Dec 2021 | $25.35 M(+149.8%) | $25.35 M(-27.9%) |
| Sep 2021 | - | $35.16 M(+1045.2%) |
| Jun 2021 | - | $3.07 M(-58.1%) |
| Mar 2021 | - | $7.34 M(-27.7%) |
| Dec 2020 | $10.15 M(+426.2%) | $10.15 M(+2062.9%) |
| Sep 2020 | - | $469.30 K(-72.1%) |
| Jun 2020 | - | $1.68 M(-44.7%) |
| Mar 2020 | - | $3.04 M(+57.7%) |
| Dec 2019 | $1.93 M(+402.0%) | $1.93 M |
| Dec 2018 | $384.30 K | - |
FAQ
- What is Kiromic BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kiromic BioPharma?
- What is Kiromic BioPharma annual cash & cash equivalents year-on-year change?
- What is Kiromic BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly cash and cash equivalents year-on-year change?
What is Kiromic BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of KRBP is $3.20 M
What is the all time high annual cash & cash equivalents for Kiromic BioPharma?
Kiromic BioPharma all-time high annual cash & cash equivalents is $25.35 M
What is Kiromic BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, KRBP annual cash & cash equivalents has changed by +$2.56 M (+396.59%)
What is Kiromic BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KRBP is $2.92 M
What is the all time high quarterly cash and cash equivalents for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly cash and cash equivalents is $35.16 M
What is Kiromic BioPharma quarterly cash and cash equivalents year-on-year change?
Over the past year, KRBP quarterly cash and cash equivalents has changed by -$1.12 M (-27.77%)